Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
HR 1260, S 515, S 610, Patent Reform Act of 2009 (Intellectual Property Issues)
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMGEN INC · Firm: AMGEN, INC.
HR 1427 and S 726, Promoting Innovation and Access to Life-Saving Medicine Act (Biosimilars) HR 1548, Pathway for Biosimilars Act (Biosimilars) S 1695, Biologics Price Competition and Innovation Act of 2007 (Biosimilars) HR 3590, Patient Protection and Affordable Care Act (Biosimilars) HR 4872, Health Care and Education Reconciliation Act (Biosimilars)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMGEN INC via AMGEN, INC.
2010 · first_quarter · Q1
Medicare Coverage and Reimbursement Issues HR 1894 and S 769, Medicare Fracture and Osteoporosis Testing Act of 2009 (DXA testing) HR 3590, Patient Protection and Affordable Care Act (End Stage Renal Disease; Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance, Independent Payment and Advisory Board) HR 4872, Health Care and Education Reconciliation Act (End Stage Renal Disease, Medicaid Drug Rebate Program, Independent Payment and Advisory Board)
HR 1260, S 515, S 610, Patent Reform Act of 2009 (Intellectual Property Issues)
Source: Senate LDA
HR 1427 and S 726, Promoting Innovation and Access to Life-Saving Medicine Act (Biosimilars) HR 1548, Pathway for Biosimilars Act (Biosimilars) S 1695, Biologics Price Competition and Innovation Act of 2007 (Biosimilars) HR 3590, Patient Protection and Affordable Care Act (Biosimilars) HR 4872, Health Care and Education Reconciliation Act (Biosimilars)
Medicare Fracture Prevention and Osteoporosis Testing Act of 2009
Client: AMGEN INC · Firm: AMGEN, INC.
Medicare Coverage and Reimbursement Issues HR 1894 and S 769, Medicare Fracture and Osteoporosis Testing Act of 2009 (DXA testing) HR 3590, Patient Protection and Affordable Care Act (End Stage Renal Disease; Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance, Independent Payment and Advisory Board) HR 4872, Health Care and Education Reconciliation Act (End Stage Renal Disease, Medicaid Drug Rebate Program, Independent Payment and Advisory Board)
HR 1260, S 515, S 610, Patent Reform Act of 2009 (Intellectual Property Issues)
HR 1260, S 515, S 610, Patent Reform Act of 2009 (Intellectual Property Issues)
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMGEN INC · Firm: AMGEN, INC.
HR 1427 and S 726, Promoting Innovation and Access to Life-Saving Medicine Act (Biosimilars) HR 1548, Pathway for Biosimilars Act (Biosimilars) S 1695, Biologics Price Competition and Innovation Act of 2007 (Biosimilars) HR 3590, Patient Protection and Affordable Care Act (Biosimilars) HR 4872, Health Care and Education Reconciliation Act (Biosimilars)
Medicare Fracture Prevention and Osteoporosis Testing Act of 2009
Client: AMGEN INC · Firm: AMGEN, INC.
Medicare Coverage and Reimbursement Issues HR 1894 and S 769, Medicare Fracture and Osteoporosis Testing Act of 2009 (DXA testing) HR 3590, Patient Protection and Affordable Care Act (End Stage Renal Disease; Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance, Independent Payment and Advisory Board) HR 4872, Health Care and Education Reconciliation Act (End Stage Renal Disease, Medicaid Drug Rebate Program, Independent Payment and Advisory Board)
Medicare Coverage and Reimbursement Issues HR 1894 and S 769, Medicare Fracture and Osteoporosis Testing Act of 2009 (DXA testing) HR 3590, Patient Protection and Affordable Care Act (End Stage Renal Disease; Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance, Independent Payment and Advisory Board) HR 4872, Health Care and Education Reconciliation Act (End Stage Renal Disease, Medicaid Drug Rebate Program, Independent Payment and Advisory Board)
HR 1427 and S 726, Promoting Innovation and Access to Life-Saving Medicine Act (Biosimilars) HR 1548, Pathway for Biosimilars Act (Biosimilars) S 1695, Biologics Price Competition and Innovation Act of 2007 (Biosimilars) HR 3590, Patient Protection and Affordable Care Act (Biosimilars) HR 4872, Health Care and Education Reconciliation Act (Biosimilars)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: AMGEN INC · Firm: AMGEN, INC.
Medicare Coverage and Reimbursement Issues HR 1894 and S 769, Medicare Fracture and Osteoporosis Testing Act of 2009 (DXA testing) HR 3590, Patient Protection and Affordable Care Act (End Stage Renal Disease; Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance, Independent Payment and Advisory Board) HR 4872, Health Care and Education Reconciliation Act (End Stage Renal Disease, Medicaid Drug Rebate Program, Independent Payment and Advisory Board)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: AMGEN INC · Firm: AMGEN, INC.
HR 1427 and S 726, Promoting Innovation and Access to Life-Saving Medicine Act (Biosimilars) HR 1548, Pathway for Biosimilars Act (Biosimilars) S 1695, Biologics Price Competition and Innovation Act of 2007 (Biosimilars) HR 3590, Patient Protection and Affordable Care Act (Biosimilars) HR 4872, Health Care and Education Reconciliation Act (Biosimilars)
HR 1427 and S 726, Promoting Innovation and Access to Life-Saving Medicine Act (Biosimilars) HR 1548, Pathway for Biosimilars Act (Biosimilars) S 1695, Biologics Price Competition and Innovation Act of 2007 (Biosimilars) HR 3590, Patient Protection and Affordable Care Act (Biosimilars) HR 4872, Health Care and Education Reconciliation Act (Biosimilars)
Intellectual Property and Process Patent Issues H.R. 1260, S. 515, S. 610, Patent Reform Act of 2009
Intellectual Property and Process Patent Issues H.R. 1260, S. 515, S. 610, Patent Reform Act of 2009
Intellectual Property and Process Patent Issues H.R. 1260, S. 515, S. 610, Patent Reform Act of 2009
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 The Affordable Health Choices Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009 H.R. 3590, Patient Protection and Affordable Care Act H.R. 3962, Affordable Healthcare for America Act
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 The Affordable Health Choices Act
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009 H.R. 3590, Patient Protection and Affordable Care Act H.R. 3962, Affordable Healthcare for America Act
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009
Medicare Fracture Prevention and Osteoporosis Testing Act of 2009
Client: AMGEN INC · Firm: AMGEN, INC.
Medicare Coverage and Reimbursement Issues H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009(End Stage Renal Disease;Comparative Effectiveness) S. 1796, America's Healthy Future Act of 2009 (Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance) H.R. 3590, Patient Protection and Affordable Care Act (End Stage Renal Disease; Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance) H.R. 3962, Affordable Healthcare for America Act (End Stage Renal Disease)
Medicare Fracture Prevention and Osteoporosis Testing Act of 2009
Client: AMGEN INC · Firm: AMGEN, INC.
Medicare Coverage and Reimbursement Issues Implementation of the Medicaid Drug Rebate Program Issues related to End Stage Renal Disease Issues related to Medicare Part D Co-pay Assistance Comparative Effectiveness H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009
Medicare Fracture Prevention and Osteoporosis Testing Act of 2009
Client: AMGEN INC · Firm: AMGEN, INC.
Medicare Coverage and Reimbursement Issues H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009(End Stage Renal Disease;Comparative Effectiveness) S. 1796, America's Healthy Future Act of 2009 (Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance)
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009
Medicare Coverage and Reimbursement Issues H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009(End Stage Renal Disease;Comparative Effectiveness) S. 1796, America's Healthy Future Act of 2009 (Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance) H.R. 3590, Patient Protection and Affordable Care Act (End Stage Renal Disease; Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance) H.R. 3962, Affordable Healthcare for America Act (End Stage Renal Disease)
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009 H.R. 3590, Patient Protection and Affordable Care Act H.R. 3962, Affordable Healthcare for America Act
Medicare Coverage and Reimbursement Issues H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009(End Stage Renal Disease;Comparative Effectiveness) S. 1796, America's Healthy Future Act of 2009 (Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance)
International Tax Reform Issues Research and Development Tax Credit S. 1203 - The Grow Research Opportunities with Tax Credits Help Act (GROWTH Act) President's Fiscal Year 2010 Revenue Proposals
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009 H.R. 3590, Patient Protection and Affordable Care Act H.R. 3962, Affordable Healthcare for America Act
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009
Medicare Coverage and Reimbursement Issues H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009(End Stage Renal Disease;Comparative Effectiveness) S. 1796, America's Healthy Future Act of 2009 (Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance) H.R. 3590, Patient Protection and Affordable Care Act (End Stage Renal Disease; Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance) H.R. 3962, Affordable Healthcare for America Act (End Stage Renal Disease)
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009 H.R. 3590, Patient Protection and Affordable Care Act H.R. 3962, Affordable Healthcare for America Act
Medicare Coverage and Reimbursement Issues H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009(End Stage Renal Disease;Comparative Effectiveness) S. 1796, America's Healthy Future Act of 2009 (Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance)
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009
Intellectual Property and Process Patent Issues H.R. 1260, S. 515, S. 610, Patent Reform Act of 2009
Intellectual Property and Process Patent Issues H.R. 1260, S. 515, S. 610, Patent Reform Act of 2009
Intellectual Property and Process Patent Issues H.R. 1260, S. 515, S. 610, Patent Reform Act of 2009
Intellectual Property and Process Patent Issues H.R. 1260, S. 515, S. 610, Patent Reform Act of 2009
Intellectual Property and Process Patent Issues H.R. 1260, S. 515, S. 610, Patent Reform Act of 2009
Intellectual Property and Process Patent Issues H.R. 1260, S. 515, S. 610, Patent Reform Act of 2009
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009 H.R. 3590, Patient Protection and Affordable Care Act H.R. 3962, Affordable Healthcare for America Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 The Affordable Health Choices Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009
Medicare Fracture Prevention and Osteoporosis Testing Act of 2009
Client: AMGEN INC · Firm: AMGEN, INC.
Medicare Coverage and Reimbursement Issues H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009(End Stage Renal Disease;Comparative Effectiveness) S. 1796, America's Healthy Future Act of 2009 (Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance)
Medicare Fracture Prevention and Osteoporosis Testing Act of 2009
Client: AMGEN INC · Firm: AMGEN, INC.
Medicare Coverage and Reimbursement Issues Implementation of the Medicaid Drug Rebate Program Issues related to End Stage Renal Disease Issues related to Medicare Part D Co-pay Assistance Comparative Effectiveness H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009
Medicare Fracture Prevention and Osteoporosis Testing Act of 2009
Client: AMGEN INC · Firm: AMGEN, INC.
Medicare Coverage and Reimbursement Issues H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009(End Stage Renal Disease;Comparative Effectiveness) S. 1796, America's Healthy Future Act of 2009 (Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance) H.R. 3590, Patient Protection and Affordable Care Act (End Stage Renal Disease; Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance) H.R. 3962, Affordable Healthcare for America Act (End Stage Renal Disease)
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009 H.R. 3590, Patient Protection and Affordable Care Act H.R. 3962, Affordable Healthcare for America Act
Medicare Coverage and Reimbursement Issues H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009(End Stage Renal Disease;Comparative Effectiveness) S. 1796, America's Healthy Future Act of 2009 (Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance) H.R. 3590, Patient Protection and Affordable Care Act (End Stage Renal Disease; Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance) H.R. 3962, Affordable Healthcare for America Act (End Stage Renal Disease)
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009 H.R. 3590, Patient Protection and Affordable Care Act H.R. 3962, Affordable Healthcare for America Act
Medicare Coverage and Reimbursement Issues H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009(End Stage Renal Disease;Comparative Effectiveness) S. 1796, America's Healthy Future Act of 2009 (Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance) H.R. 3590, Patient Protection and Affordable Care Act (End Stage Renal Disease; Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance) H.R. 3962, Affordable Healthcare for America Act (End Stage Renal Disease)
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009 H.R. 3590, Patient Protection and Affordable Care Act H.R. 3962, Affordable Healthcare for America Act
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 The Affordable Health Choices Act
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009
FDA Drug Safety Oversight Follow-On-Biologics H.R. 1038, Access to Life-saving Medicines Act H.R. 1956, Patient Protection and Innovative Biologics Medicines Act of 2007 HR. 5629, Pathway for Biosimilars Act
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: AMGEN INC · Firm: AMGEN, INC.
FDA Drug Safety Oversight Follow-On-Biologics H.R. 1038, Access to Life-saving Medicines Act H.R. 1956, Patient Protection and Innovative Biologics Medicines Act of 2007 HR. 5629, Pathway for Biosimilars Act
FDA Drug Safety Oversight Follow-On-Biologics H.R. 1038, Access to Life-saving Medicines Act H.R. 1956, Patient Protection and Innovative Biologics Medicines Act of 2007 HR. 5629, Pathway for Biosimilars Act
Intellectual property and process patent issues S. 1145 and H.R.. 1908 Patent Reform Act of 2007
Follow-On-Biologics S. 623 and H.R. 1038 – Access to Life-Saving Medicines Act H.R. 1956 – Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1695 - Biologics Price Competition and Innovation Act of 2007 FDA Drug Safety Oversight S.1082 – Prescription Drug User Fee Amendments of 2007 H.R. 2900 – Food and Drug Administration Amendments Act of 2007
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: AMGEN INC · Firm: AMGEN, INC.
Follow-On-Biologics S. 623 and H.R. 1038 – Access to Life-Saving Medicines Act H.R. 1956 – Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1695 - Biologics Price Competition and Innovation Act of 2007 FDA Drug Safety Oversight S.1082 – Prescription Drug User Fee Amendments of 2007 H.R. 2900 – Food and Drug Administration Amendments Act of 2007
Follow-On-Biologics S. 623 and H.R. 1038 – Access to Life-Saving Medicines Act H.R. 1956 – Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1695 - Biologics Price Competition and Innovation Act of 2007 FDA Drug Safety Oversight S.1082 – Prescription Drug User Fee Amendments of 2007 H.R. 2900 – Food and Drug Administration Amendments Act of 2007
FDA Drug Safety Oversight H.R. 2900, Prescription Drug User Fee Amendments of 2007 H.R. 3580, Food and Drug Administration Amendments Act of 2007 Follow-On-Biologics
FDA Drug Safety Oversight H.R. 2900, Prescription Drug User Fee Amendments of 2007 H.R. 3580, Food and Drug Administration Amendments Act of 2007 Follow-On-Biologics
Intellectual property and process patent issues S. 1145 and S. 1908 – Patent Reform Act of 2007
Intellectual property and process patent issues S. 1145 and H.R.. 1908 Patent Reform Act of 2007
Follow-On-Biologics S. 623 and H.R. 1038 – Access to Life-Saving Medicines Act H.R. 1956 – Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1695 - Biologics Price Competition and Innovation Act of 2007 FDA Drug Safety Oversight S.1082 – Prescription Drug User Fee Amendments of 2007 H.R. 2900 – Food and Drug Administration Amendments Act of 2007
A bill to amend the procedures regarding military recruiter access to secondary school student recruiting information.
Client: AMGEN INC · Firm: AMGEN, INC.
Intellectual property and process patent issues S. 1145 and S. 1908 – Patent Reform Act of 2007
Follow-On-Biologics S. 623 and H.R. 1038 – Access to Life-Saving Medicines Act H.R. 1956 – Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1695 - Biologics Price Competition and Innovation Act of 2007 FDA Drug Safety Oversight S.1082 – Prescription Drug User Fee Amendments of 2007 H.R. 2900 – Food and Drug Administration Amendments Act of 2007
H.R. 6257: Access to Life-Saving Medicine Act S. 4016: Access to Life-Saving Medicine Act S. 3807: Enhancing Drug Safety and Innovation Act of 2006 Implementation of H.R. 1 Medicare Prescription Drug & Modernization Act of 2003 Medicare and Medicaid Reimbursement Follow-On-Biologics FDA Drug Safety Oversight
Intellectual Property and Process Patent Issues H.R. 2795: Patent Act of 2005 S. 3818: Patent Reform Act of 2006
H.R. 6257: Access to Life-Saving Medicine Act S. 4016: Access to Life-Saving Medicine Act S. 3807: Enhancing Drug Safety and Innovation Act of 2006 Implementation of H.R. 1 Medicare Prescription Drug & Modernization Act of 2003 Medicare and Medicaid Reimbursement Follow-On-Biologics FDA Drug Safety Oversight
International Tax Reform Issues Research and Development Tax Credit
HR 1427 and S 726, Promoting Innovation and Access to Life-Saving Medicine Act (Biosimilars) HR 1548, Pathway for Biosimilars Act (Biosimilars) S 1695, Biologics Price Competition and Innovation Act of 2007 (Biosimilars) HR 3590, Patient Protection and Affordable Care Act (Biosimilars) HR 4872, Health Care and Education Reconciliation Act (Biosimilars)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN INC via AMGEN, INC.
2009 · fourth_quarter · Q4
Intellectual Property and Process Patent Issues H.R. 1260, S. 515, S. 610, Patent Reform Act of 2009
International Tax Reform Issues Research and Development Tax Credit
Medicare Coverage and Reimbursement Issues H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009(End Stage Renal Disease;Comparative Effectiveness) S. 1796, America's Healthy Future Act of 2009 (Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance) H.R. 3590, Patient Protection and Affordable Care Act (End Stage Renal Disease; Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance) H.R. 3962, Affordable Healthcare for America Act (End Stage Renal Disease)
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009 H.R. 3590, Patient Protection and Affordable Care Act H.R. 3962, Affordable Healthcare for America Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via AMGEN, INC.
2009 · third_quarter · Q3
Medicare Coverage and Reimbursement Issues H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009(End Stage Renal Disease;Comparative Effectiveness) S. 1796, America's Healthy Future Act of 2009 (Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance)
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, The Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009
International Tax Reform Issues Research and Development Tax Credit
Intellectual Property and Process Patent Issues H.R. 1260, S. 515, S. 610, Patent Reform Act of 2009
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via AMGEN, INC.
2009 · second_quarter · Q2
Intellectual Property and Process Patent Issues H.R. 1260, S. 515, S. 610, Patent Reform Act of 2009
Biosimilars H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilars Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 The Affordable Health Choices Act
International Tax Reform Issues Research and Development Tax Credit S. 1203 - The Grow Research Opportunities with Tax Credits Help Act (GROWTH Act) President's Fiscal Year 2010 Revenue Proposals
Medicare Coverage and Reimbursement Issues Implementation of the Medicaid Drug Rebate Program Issues related to End Stage Renal Disease Issues related to Medicare Part D Co-pay Assistance Comparative Effectiveness H.R. 1894 and S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN INC via AMGEN, INC.
2008 · first_quarter · Q1
FDA Drug Safety Oversight Follow-On-Biologics H.R. 1038, Access to Life-saving Medicines Act H.R. 1956, Patient Protection and Innovative Biologics Medicines Act of 2007 HR. 5629, Pathway for Biosimilars Act
Medicare Coverage and Reimbursement Issues Implementation of the Medicaid Drug Rebate Program
Intellectual property and process patent issues S. 1145 and H.R.. 1908 Patent Reform Act of 2007
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN INC via AMGEN, INC.
2007 · year_end · YY
Intellectual property and process patent issues S. 1145 and H.R.. 1908 Patent Reform Act of 2007
FDA Drug Safety Oversight H.R. 2900, Prescription Drug User Fee Amendments of 2007 H.R. 3580, Food and Drug Administration Amendments Act of 2007 Follow-On-Biologics
Medicare Coverage and Reimbursement Issues Implementation of H.R. 1 Medicare Prescription Drug & Modernization Act of 2003 Implementation of the Medicaid Drug Rebate Program H.R. 3162, Children's Health and Medicare Protection Act of 2007
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
AMGEN INC via AMGEN, INC.
2007 · mid_year · MM
Implementation of H.R. 1 Medicare Prescription Drug & Modernization Act of 2003 Medicare coverage and reimbursement of Erythropoiesis-Stimulating Agents Implementation of Medicaid Drug Rebate provisions of the Deficit Reduction Act of 2005
Intellectual property and process patent issues S. 1145 and S. 1908 – Patent Reform Act of 2007
Corporate Tax Issues
AMGEN INC via AMGEN, INC.
2006 · year_end · YY
Intellectual Property and Process Patent Issues
H.R. 6257: Access to Life-Saving Medicine Act S. 4016: Access to Life-Saving Medicine Act S. 3807: Enhancing Drug Safety and Innovation Act of 2006 Implementation of H.R. 1 Medicare Prescription Drug & Modernization Act of 2003 Medicare and Medicaid Reimbursement Follow-On-Biologics FDA Drug Safety Oversight
Implementation of H.R. 1 Medicare Prescription Drug & Modernization Act of 2003 Medicare and Medicaid Reimbursement H.R. 6111: Tax Relief and Health Care Act of 2006
AMGEN INC via AMGEN, INC.
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
AMGEN INC via AMGEN, INC.
2005 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN INC via AMGEN, INC.
2004 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN INC via AMGEN, INC.
2003 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN INC via AMGEN, INC.
2003 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Follow-On-Biologics S. 623 and H.R. 1038 – Access to Life-Saving Medicines Act H.R. 1956 – Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1695 - Biologics Price Competition and Innovation Act of 2007 FDA Drug Safety Oversight S.1082 – Prescription Drug User Fee Amendments of 2007 H.R. 2900 – Food and Drug Administration Amendments Act of 2007
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
Corporate Tax Issues
Intellectual Property and Process Patent Issues H.R. 2795: Patent Act of 2005 S. 3818: Patent Reform Act of 2006
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE